Vimarsana
Biggest News Aggregation in the World

Goki Ishikawa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Goki Ishikawa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Goki Ishikawa Today - Breaking & Trending Today

Fujirebio and Agappe Enter into an Agreement on Business Collaboration in the Field of CLIA Based Immunoassay - Vimarsana News

Fujirebio and Agappe Enter into an Agreement on Business Collaboration in the Field of CLIA Based Immunoassay

Fujirebio Holdings Inc. and Agappe Diagnostics Ltd today announced that they have entered into an agreement of Contract Development and Manufacturing Organization CDMO partnership for Cartridge based CLIA system reagents manufacturing project for the immunology equipment Mispa i60 and Mispa i121.

Fujirebio Expands Its Alzheimers Disease Test Menu With the Much Awaited and Fully Automated Lumipulse G pTau 217 Plasma Assay for Research Use Only RUO - Vimarsana News

Fujirebio Expands Its Alzheimers Disease Test Menu With the Much Awaited and Fully Automated Lumipulse G pTau 217 Plasma Assay for Research Use Only RUO

H.U. Group Holdings Inc. and its whollyowned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 Plasma assay for the fully automated LUMIPULSE G immunoassay systems.

Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay - Vimarsana News

Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay

Fujirebio Holdings Inc. President CEO Goki Ishikawa and Sysmex Corporation President Kaoru Asano today announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies the Agreement.

Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration - Vimarsana News

Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration

Fujirebio Holdings Inc. President CEO Goki Ishikawa and Sysmex Corporation President Kaoru Asano today announced that they have entered into an agreement to expand their Contract Development and Manufacturing Organization CDMO partnership for Sysmexs Automated Immunoassay System HISCLSeries.

GHIT Fund Welcomes Fujirebio as New Funding Partner - Vimarsana News

GHIT Fund Welcomes Fujirebio as New Funding Partner

/PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is pleased to announce today to welcome an R&D-driven company Fujirebio Holdings Inc....